LOX-IN-3

CAS: 2409963-83-1 货号: L655479 分子式: C13H13FN2O2S 分子量: 280.32 PubChem CID: 146317833
有货
级别和纯度: 10mM in DMSO
别名
液氧-IN-3
储存条件
避光,-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
L655479-1ml
期货 Stock Image
¥4,180.90
请输入您要添加的产品数量

概述


LOX-IN-3 is an orally active lysyl oxidase (LOX) inhibitor. LOX-IN-3 can be used for fibrosis, cancer and angiogenesis research

In Vitro

LOX-IN-3 dihydrochloride monohydrate (Compound 33) inhibits the bovine LOX and human LOXL2 activities with IC 50 values of <10 μM and <1 μM, respectively. LOX-IN-3 dihydrochloride monohydrate exhibits sustained inhibition of LOXL1 and LOXL2. LOX-IN-3 dihydrochloride monohydrate is less active against SSAO/VAP-1 and MAO-B activities. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

LOX-IN-3 dihydrochloride monohydrate (Compound 33) (30 mg/kg; orally; once) inhibits lysyl oxidase activity in rats . LOX-IN-3 dihydrochloride monohydrate (10 mg/kg; orally; daily for 14 days) reduces kidney fibrosis in unilateral ureteric obstruction (UUO) mice model . LOX-IN-3 dihydrochloride monohydrate (15 mg/kg; orally; daily for 21 days) reduces lung fibrosis in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Wistar rats Dosage: 30 mg/kg Administration: Oral administration, single dose Result: Completely abolished lysyl oxidase activity. Plasma concentrations of tested compound are far below the IC 50 after 8 hours, the half-life of recovery is between 2-3 days (ear) and 24 hours (aorta). Animal Model: Unilateral ureteric obstruction (UUO) model of acute kidney fibrosis in mice Dosage: 10 mg/kg Administration: Oral gavage, daily for 14 days Result: Increased kidney weight and thickness and reduced the area of fibrosis. Animal Model: C57Bl/6 mice, Bleomycin-induced lung fibrosis model Dosage: 15 mg/kg Administration: Oral gavage, daily for 21 days Result: Significantly reduced the Ashcroft score and the lung weight.

IC50& Target:IC 50 : <1 μM (human LOXL2), <10 μM (bovine LOX)

规格

别名
液氧-IN-3
规格或纯度
10mM in DMSO
英文名称
LOX-IN-3
生化机理
LOX-IN-3 是一种口服活性赖氨酰氧化酶(LOX)抑制剂。LOX-IN-3 可用于纤维化、癌症和血管生成研究。
储存条件
避光,-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
分子类型
小分子
Isomeric SMILES
C1=CC2=C(C(=C1)S(=O)(=O)C/C(=C/CN)/F)N=CC=C2
关联CAS
PubChem CID
分子量
280.32

高级数据

安全和危险性(GHS)
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器

常见问题

本产品应如何储存?
请于?80 °C、避光条件下保存。本品对光敏感,请保存在原始的避光或棕色容器中。
本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 2409963-83-1,分子式为 C13H13FN2O2S,分子量为 280.32 g/mol。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。